TGFB1 and Duchenne muscular dystrophy: Thus, they tested >1500 molecules from the Johns Hopkins Clinical Compound Library and selected those that enhanced the myogenic fusion of DMD cells, such as ginsenoside Rd, belonging to the FKT3 signaling pathway, and fenofibrate, linked to TGF-β signaling.